Omicron threat: Pakistan further lowers age limit for COVID-19 booster dose
From tomorrow onwards, citizens over 18 years will be eligible for a free booster dose of their choice
Pakistan on Friday further lowered the age limit for booster doses amid a sharp rise in the coronavirus positivity ratio that has crossed 7%.
The National Command and Operations Centre (NCOC) said that from tomorrow onwards, citizens over 18 years will be eligible for a free booster dose of their choice.
Earlier, people of 30 years of age or above were allowed booster jabs.
“In today’s NCOC session, the age limit for a booster dose has been further reduced. From tomorrow onwards, citizens over 18 years will be eligible for a free booster dose of their choice. Booster (one dose) will be administered after 6 months gap from complete vaccination,” the apex COVID-19 body said in an announcement.
The NCOC is also mulling to impose restrictions on weddings as large gatherings have proved to be “super-spreaders” of COVID-19 in the past and the same is happening now.
Pakistan records over 3,500 cases
The country reported 3,567 new cases — the highest since September 10, 2021 — in the last 24 hours, the NCOC data showed Friday morning.
The NCOC said 48,449 tests were conducted across the country, and 3,567 infections emerged, taking the positivity ratio to 7.36%. The country last reported an infection rate of 6.64% on August 31, 2021.
With the new infections, the overall tally has risen to 1.315 million, while seven more deaths have taken the death toll to 28,999.
-
Always tired and foggy? This vitamin deficiency could be the clue
-
Is loneliness becoming the next global health crisis?
-
Ebola outbreak: Congo faces deadliest crisis with over 3,000 deaths
-
New report reveals, children as young as six going to A&E in mental health crisis
-
'Self-exercising' muscle implants developed by researchers offer workout benefits without movement
-
GLP-1 drugs cut US obesity from 39.9% to 36.4%
-
New clinical trial highlights precision-dosing strategy for vitamin D deficiency management
-
Cyclospora outbreak: USDA research projects shelved amid funding cuts and relocations

